Found 1818 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
N. A. Terrault, Roland, M. E., Schiano, T., Dove, L., Wong, M., Poordad, F., Ragni, M. V., Barin, B., Simon, D., Olthoff, K. M., Johnson, L., Stosor, V., Jayaweera, D., Fung, J., Sherman, K. E., Subramanian, A., Millis, J., Slakey, D., Berg, C., Carlson, L., Ferrell, L., and Stablein, D., Outcomes of Liver Transplant Recipients with Hepatitis C and Human Immunodeficiency Virus Coinfection, Liver Transpl, vol. 18, pp. 716-726, 2012.
I. Tellez, Sabbaj, S., Peng, X., Mulligan, M. J., and AVEG], theN. I. H. A. I. D. S. V., T cell and antibody responses in HIV-1 seronegative volunteers immunized with recombinant canarypox and gp120 prime-boost vaccines, 1999.
A. Tejani and Sullivan, E. K., Factors that Impact on the Outcome of Second Renal Transplants in Children, Transplantation, vol. 62, no. 5, pp. 606-611, 1996.
A. Tejani, Harmon, W. E., Benfield, M., Elshihabi, I., McDonald, R., Stablein, D., Rose, S., Strom, T., and Suthanthiran, M., A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation, 2000.
A. Tejani, Harmon, W. E., Benfield, M., Elshihabi, I., McDonald, R., Stablein, D., Rose, S., Strom, T., and Suthanthiran, M., randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation, 2000.
A. Tejani, Stablein, D., Alexander, S., Fine, R., and Harmon, W., Analysis of Rejection Outcomes and Implications. A Report of the North American Pediatric Renal Transplant Cooperative Study, Transplantation, vol. 59, no. 4, pp. 500-504, 1995.
A. Tejani, Harmon, W. E., Benfield, M., Elshihabi, I., McDonald, R., Stablein, D., Rose, S., Strom, T., and Suthanthiran, M., A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation, 2000.
A. Tejani, Sullivan, E. K., ,, Fine, R. N., Harmon, W. E., and Kohaut, E. C., Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Transplantation, vol. 3, pp. 293-300, 1999.
A. Tejani, Stablein, D. M., Donaldson, L., Harmon, W. E., ,, Kohaut, E., Emmett, L., and Fine, R. N., Steady improvements in short-term graft survival of pediatric renal transplants: The North American Pediatric Transplant Cooperative Study (NAPRTCS) experience, Clinical Transplants, 1999.
A. Tejani and Sullivan, E. K., Higher Maintenance Cyclosporine Dose Decreases the Risk of Graft Failure in North American Children: A Report of the North American Pediatric Renal Transplant Cooperative Study, J Am Soc Nephrol, vol. 7, no. 4, pp. 550-555, 1996.
A. H. Tejani, Sullivan, E. K., Harmon, W. E., Fine, R. N., Kohaut, E., Emmett, L., and , Renal Transplantation - The NAPRTCS Experience. Los Angeles: UCLA Tissue Typing Laboratory, 1998, p. 13.
A. H. Tejani, Stablein, D. M., Sullivan, E. K., ,, Fine, R. N., Harmon, W. E., and Kohaut, E. C., The impact of donor source, recipient age, preoperative immunotherapy and induction therapy on early and late acute rejections in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Transplantation, vol. 2, pp. 318-24, 1998.
A. Tejani and Sullivan, E. K., The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Transplantation, vol. 4, pp. 1-7, 1999.
A. Tejani, Stablein, D. M., and Ho, P. L., Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials, 2002.
A. Tejani, Stablein, D. M., Donaldson, L., Harmon, W. E., ,, Kohaut, E., Emmett, L., and Fine, R. N., Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience, Clin Transplant, pp. 95-110, 1999.
A. Tejani and Sullivan, E. K., Should living-related renal transplant be performed for primary oxalosis?, 2000.
A. Tejani and Sullivan, E. K., Do six-antigen matched cadaver donor (CAD) kidneys provide better graft survival to children compared to one-haploidentical living-related (LRD) transplants? A report of the North American Pediatric Cooperative Study (NAPRTCS), 1999.
T. Trans- Dent Team, Metadata - The common denominator for the dental PBRNs, 2006.
C. TE, The overlapping coefficient for two normal probability functions with unequal variances., 1997.
C. TE, Validity of JVA interpretation in conjunction with RDC history & clinical examination to assess TMD,, 1997.
C. TE, The overlapping coefficient for two normal probability functions with unequal variances., 1997.
S. N. Taylor, Marrazzo, J., Batteiger, B. E., Hook, E. W., Seña, A. C., Long, J., Wierzbicki, M. R., Kwak, H., Johnson, S. M., Lawrence, K., and Mueller, J., Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea., N Engl J Med, vol. 379, no. 19, pp. 1835-1845, 2018.
H. A. Taylor, Brown, A., Burchfield, C., Clemons, T., Arne, D., Skelton, T., Garrison, R., and Jones, D., Pulse pressure: Potent predictor of coronary disease risk in a biracial cohort of normo- and hypertensives, Circulation, vol. 100, p. 230, 1999.
C. O. Taylor, Barr, M. L., Radovancevic, B., Renlund, D. G., Mentzer, Jr., R. M., Smart, F. W., Tolman, D. E., Frazier, O. H., Young, J. B., and Van Veldhuisen, P., A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardia transplantation: decreased hyperlipidemia and hypertension with tacrolimus, J Heart Lung Transplant, vol. 18, pp. 336-345, 1999.
M. D. Tapia, Sow, S. O., Lyke, K. E., Haidara, F. C., Diallo, F., Doumbia, M., Traore, A., Coulibaly, F., Kodio, M., Onwuchekwa, U., Sztein, M. B., Wahid, R., Campbell, J. D., Kieny, M. P., Moorthy, V., Imoukhuede, E. B., Rampling, T., Roman, F., De Ryck, I., Bellamy, A. R., Dally, L., Mbaya, O. T., Ploquin, A., Zhou, Y., Stanley, D. A., Bailer, R., Koup, R. A., Roederer, M., Ledgerwood, J., Hill, A. V. S., Ballou, W. R., Sullivan, N., Graham, B., and Levine, M. M., Use of ChAd3-EBO-Z Ebola Virus Vaccine in Malian and US Adults, and Boosting of Malian Adults with MVA-BN-Filo, Lancet Infect Dis, vol. 16, no. 1, pp. 31-42, 2016.